santa cruz biotechnology, inc.
SCBT Logo

Welcome!        Items in Cart     Quick Order
 

Kinase Inhibitors

  • 1-(5-Isoquinolinesulfonyl)-3-methylpiperazine, hydrochloride
    A selective inhibitor of protein kinase C or cyclic-nucleotide-dependent protein kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-213276141543-65-9C14H17N3O2S•HCl25 mg
  • 1-(5-Isoquinolinesulfonyl)piperazine Hydrochloride
    Exhibits potent inhibition toward protein kinase C and cyclic nucleotide dependent protein kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-213277141543-63-7C13H16ClN3O2S25 mg
  • 1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine dihydrochloride
    A lesser potent inhibitor of phosphokinase C than H-7.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-213278140663-38-3C14H19Cl2N3O2S5 mg/25 mg
  • 1-Naphthyl PP1
    A kinase inhibitor that inhibits src family kinses v-Src, c-Fyn, and the proto-oncogene c-Abl.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203765221243-82-9C19H19N510 mg/50 mg
  • 1,2,3,4-Tetrahydro Staurosporine
    Staurosporine derivative used as an isoenzyme PKCå inhibitor and as an anticancer agent.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-206233220038-19-7C28H30N4O3500 µg
  • 1,3-Bis-(o-tert-butyldimethylsilyl)-Fmoc-D-erythro-sphingosine
    Protected Sphingosine.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-213489N/AC45H75NO4Si225 mg
  • 2-Aminopurine Dihydrochloride
    A purine analog that acts as a protein kinase inhibitor. It acts as a mutagen, can override checkpoints of the cell cycle and induce S-phase arrested cells to enter mitosis incorrectly.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20152476124-64-6C5H5N5•2HCl100 mg/500 mg
  • 2-Azido-1-pivaloyl-D-erythro-Sphingosine
    A derivative of Sphingosine. A selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Also inhibits calmodulin-dependent enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-206402114275-41-1C23H43N3O320 mg
  • 2-Bromoaldisine
    Inhibitor of the Raf/MEK-1/MAPK cascade (IC50= 539nM).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20288096562-96-8C8H7BrN2O20.5 mg
  • 2,3,6-Trideoxy-Ins(1,4,5)P3. 6Na
    Exhibits relatively low ligand binding affinity to the Ins(1,4,5)P3 receptor of bovine adrenal cortex membranes and acts as a weak agonist in releasing calcium from saponin permeablized SH-Sy5Y human neurolastoma cells.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-220787N/AN/A1 mg
  • (2S,3R,4E)-2-Azido-3-(tert-butyldimethylsilyl)-1-pivaloyl-erythro-sphingosine
    A derivative of Sphingosine. Selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Inhibits calmodulin-dependent enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-206567114275-42-2C29H57N3O3Si20 mg
  • (2S,3R,4E)-2-Azido-3-(tert-butyldimethylsilyl)-erythro-sphingosine
    A derivative of Sphingosine, a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Also inhibits calmodulin-dependent enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-206568114299-64-8C24H49N3O2Si10 mg
  • 3-O-(tert-Butyldimethylsilyloxy)-2-Fmoc-erythro-sphingosine
    A derivative of Sphingosine that is a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. This compound does not inhibit protein kinase A or myosin light chain kinase, but does inhibit calmodulin-dependent enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-206670149035-77-8C39H61NO4Si10 mg
  • 3-O-(tert-Butyldimethylsilyloxy)-erythro-sphingosine
    This derivative of Sphingosine is a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. This compound does not inhibit protein kinase A or myosin light chain kinase, although it inhibits calmodulin-dependent enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-206671137905-29-4C24H51NO2Si10 mg
  • 3,4-Dihydro-2H,10H-azepino[3,4-b]indole-1,5-dione Methanesulfonate Salt
    A myt1 kinase inhibitor used in the treatment of proliferative diseases
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20670368724-84-5C13H14N2O5S5 mg
  • 4-Amino-1-tert-butyl-3-(3-methylbenzyl)pyrazolo[3,4-d]pyrimidine
    A highly potent and uniquely specific tyrosine kinase inhibitor of v-Src tyrosine kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-206805956025-83-5C17H21N510 mg
  • 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide
    A potent benzimidazole analog that inhibits IKK-ε with an IC50 value of ~15.8 µM, where IKK-ε is mostly expressed n immune cells and thought to play a role in immune response.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205128916985-21-2C22H21N3O6S21 mg/5 mg
  • 5-Iodo-Indirubin-3'-monoxime
    A highly potent of glycogen synthase kinase-3β inhibitor. Also inhibits Cdk1 and Cdk5 activities. Acts by binding to the ATP-binding pocket of these enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221754N/AC16H10IN3O21 mg
  • 5'-Tosyl Thymidine
    A nucleoside analogue used as inhibitors of thymidylate kinases
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2070747253-19-2C17H20N2O7S250 mg
  • 7-Azaoxindole
    Used for preparation of 3-(anilinomethylene) oxindoles and analogs as protein tyrosine kinase and protein serine/threonine kinase inhibitors.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2071555654-97-7C7H6N2O100 mg
  • 7,8-Dihydro-9-[2-(4-bromophenyl)hydrazone]-5H-pyrido[3,2-b]azepine-6,9-dione
    A GSK-3 inhibitor used
    Catalog #CAS NumberMolecular FormulaUnit
    sc-207184676596-64-8C15H13BrN4O10 mg
  • A 419259 trihydrochloride
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361094364042-47-7C29H34N6O•3HCl10 mg
  • A 83-01
    Selective inhibitor of TGF-β type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TGF-β-induced epithelial-to-mesenchymal transition. Only weakly inhibits ALK-1, -2, -3, -6 and MAPK activity. More potent than SB 431542.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203791909910-43-6C25H19N5S10 mg/50 mg
  • AAL-993
    A highly potent inhibitor of VEGFR-1, VEGFR-2 and VEGFR-3 (IC50=130nM, IC50=23nM and IC50=18nM respectively). At higher concentrations it inhibits PDGFR-β (640nM), c-Kit (236nM) and CSF-1R (380nM).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221195269390-77-4C20H16N3OF35 mg/25 mg
  • Adenosine Kinase Inhibitor
    Cell-permeable. Acts as a potent, adenosine-competitive, and reversible adenosine kinase (AK) inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202900214697-26-4C22H19BrN6O•2HCl•xH2O5 mg
  • Adaphostin
    A p210bcr/abl tyrosine kinase inhibitor (IC50 = 14 μM). Induces apoptosis in T-lymphoblastic human leukemia cell lines (IC50 values range from 16.8 to 216.3 nM) in vitro. Has been shown to display selectivity for chronic myelogenous leukemia (CML) myeloid progenitors in vitro.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-291833241127-58-2C24H27NO410 mg/50 mg
  • AEG 3482
    Cell-permeable imidazothiadiazole compound that activates HSF1 by binding to HSP90 and disrupting its association with HSF1.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20291163735-71-7C10H8N4O2S25 mg
  • (+)-Aeroplysinin-1
    Displays cytostatic and cytotoxic activity. Inhibitor of EGFR kinase. Shows antiangiogenic activity.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20244528656-91-9C9H9Br2NO31 mg
  • AG 43
    An inactive tyrphostin analogue that can be used a negative control parameter for other tyrphostins.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2029165553-97-9C10H8N2O5 mg
  • AG 556
    Selectively inhibits EGF receptor kinase autophosphorylation (IC50 = 5 µM) over HER1/2 autophosphorylation. Also blocks LPS-induced TNF-α production.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202044133550-41-1C20H20N2O35 mg/25 mg
  • AG-1296
    A potent inhibitor of PDGF receptor tyrosine kinase (IC50=1 µM). Inhibits FGF receptor tyrosine kinase and c-kit.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-200631146535-11-7C16H14N2O25 mg/25 mg
  • AG-490
    A tyrosine kinase inhibitor that belongs to the family of tyrphostins. Compound has been reported to inhibit JAK2 and not JAK1, Lck, Btk, Tyk2, Syk, Lyn, and Src.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202046134036-52-5C17H14N2O310 mg/50 mg
  • Akt Inhibitor
    A phosphatidylinositol ether analog that potently and selectively inhibits Akt (PKB) (IC50 of 5.0 µM). Moderately inhibits PI 3-K activity (IC50 = 83.0 µM). Also inhibits the growth of various cancer cell lines with IC50 values in the 1 - 10 µM range.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221226N/AC30H58O101 mg
  • Akt Inhibitor III
    A phosphatidylinositol analog that inhibits the activation of Akt and select downstream substrates without decreasing phosphorylation of PDK-1 or other kinases downstream of Ras, such as MAPK.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221228N/AC28H57O9P1 mg
  • Akt Inhibitor IV
    Inhibitor of Akt protein kinase and reported to inhibit the ATP-binding site of kinase upstream of AKT and downstream of PI3K.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203809681281-88-9C31H27IN4S1 mg/5 mg
  • Akt Inhibitor IX, API-59CJ-OMe
    A cell-permeable ellipticine compound that selectively and potently induces apoptosis in human endometrial cancer cells (RL95-2 and Ishikawa) that exhibit elevated Akt activity (effective concentration = 12-24 µM), but not on cells with low Akt activity.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20381098510-80-6C21H22N2O3 ·3H2O5 mg
  • Akt Inhibitor X
    A cell permeable, reversible, and selective inhibitory phenoxazine that suppresses the kinase reactivity of Akt by inhibiting its phosphorylation.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203811925681-41-0C20H25ClN2O ·HCl5 mg
  • Akt Inhibitor XI
    A cell-permeable copper complex that interacts with both the PH and the kinase domains of Akt and potently inhibits its kinase activity. Inhibits tumor growth both in cultured cells in vitro and in mice in vivo without any apparent adverse effect to the animals.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221229N/AC11H9Cl2CuN3O2S5 mg
  • Akt Inhibitor XII, Isozyme-Selective, Akti-2
    A cell-permeable Akti-1/2- (sc-202048) derived allosteric inhibitor pair (1:1 regioisomeric mixture) with much improved aqueous solubility (10 mg/ml in a pH 7.4 saline) and Akt2 selectivity (IC50 = 805 nM for Akt2, >10 µM for Akt1/3, and >50 µM for PKA/PKC/SGK). The inhibition is PH domain-dependent and non-competitive with ATP.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221230N/AC39H39N7O2 ·3HCl2 mg
  • Akt Inhibitor XIII, Isozyme-Selective, Akti2-1/2
    A highly cell-permeable and water soluble analog of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (sc-202048) that acts as a plecktrin homology (PH)-domain dependent, non-ATP competitive and an allosteric inhibitor of Akt1/2 (IC50 = 560 nM, 390 nM and 7.8 µM in in vitro kinase assay; 526 nM, 730 nM and > 10 µM in LNCaP cells for Akt1, Akt2 and Akt3, respectively) with ~ 80-fold greater selectivity over PKA, PKC and SGK (IC550> 50 µM). One of its potent regioisomers (C7-substituted) is shown to enhance induced caspase-3 activity in several tumor cells.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221231N/AC40H43N7O2 ·3HCl2 mg
  • AP 24534
    Catalog #CAS NumberMolecular FormulaUnit
    sc-362710943319-70-8C29H27F3N6O10 mg/50 mg
  • Apigenin
    Inhibits MAP kinase-associated signal transduction pathways and proliferation of malignant tumor cells by causing G2/M arrest and induces morphological differentiation.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3529520-36-5C15H10O55 mg/100 mg
  • AS-604850
    This is a potent, cell permeable and ATP-competitive inhibitor of phosphoinositide 3-kinase γ (PI(3)Kγ). it exhibits selectivity over other PI(3)K isoforms.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221271648449-76-7C11H5F2NO4S1 mg/5 mg
  • AS-605240
    This is a potent, cell permeable and ATP-competitive inhibitor of phosphoinositide 3-kinase γ (PI(3)Kγ). It exhibits selectivity over other PI(3)K isoforms.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221272648450-29-7C12H7N3O2S1 mg/5 mg
  • ATM Kinase Inhibitor
    A cell-permeable, potent, selective and ATP-competitive inhibitor of ATM (Ataxia telangiectasia mutated). Shows inhibition specificity for other phosphatidylinositol 3'-kinase-like kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202963587871-26-9C21H17NO3S22 mg
  • ATM/ATR Kinase Inhibitor
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202964905973-89-9C23H18Cl3FN4O3S5 mg
  • Aurora Kinase Inhibitor II
    Aurora Kinase Inhibitor II is an anilinoquinazoline that is both a potent and selective ATP-competitive inhibitor of Aurora kinases and has the ability to permeate the cell.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203827331770-21-9C23H20N4O31 mg
  • Aurora Kinase Inhibitor III
    A cell-permeable 2,4-dianilinopyrimidine compound that acts as an ATP-competitive, potent, but non-selective inhibitor of Aurora A (IC50 = 42 nM). At higher concentrations, inhibits the activities of other kinases, such as Lck, Bmx, IGF-1R, and Syk as well(IC50 = 131, 386, 591, and 887 nM, respectively).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203828879127-16-9C21H18F3N5O1 mg
  • Avenanthramide-C methyl ester
    Avenanthramide-C methyl ester inhibits NF-κB activation by blocking the phosphorylation of IKK and IκB (IC50 ~ 40 μM). Through this mechanism, avenanthramide-C methyl ester dose dependently inhibits the secretion and expression of IL-6, IL-8, and MCP-1 in human aortic endothelial cells.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-223786955382-52-2C17H15NO6500 µg/1 mg
  • AZ 3146
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3611141124329-14-1C24H32N6O310 mg/50 mg
  • Azido-erythro-sphingosine
    A derivative of Sphingosine. A selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Also inhibits calmodulin-dependent enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-207312103348-49-8C18H35N3O225 mg
  • BAY R3401
    A glycogen phosphorylase inhibitor shown to suppress hepatic glycogenolysis.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-239281100276-03-7C20H22ClNO45 mg
  • BC 11 hydrobromide
    Catalog #CAS NumberMolecular FormulaUnit
    sc-362712443776-49-6C8H11BN2O2S.HBr10 mg/50 mg
  • Bcr-abl Inhibitor II
    A cell-permeable thiadiazole compound that acts as an ATP binding site-targeting inhibitor of Abl and c-Src kinases (Ki = 44 and 354 nM, respectively). Effectively inhibits cellular Bcr-Abl Tyr245 phosphorylation and the clonogenic activity of Bcr-Abl-transformed 32D cells, regardless of their resistance to Imatinib/STI571.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221289N/AC16H11F2N3OS25 mg
  • BI 78D3
    Competitive c-Jun N-terminal kinase (JNK) inhibitor (IC50 = 280 nM) that displays > 100 fold selectivity over p38α and no activity at mTOR and PI-3K. Inhibits JNK interacting protein 1 (JIP1)-JNK binding (IC50 = 500 nM) and prevents JNK substrate phosphorylation. Restores insulin sensitivity in a mouse model of type II diabetes and blocks JNK-dependent Con A-induced liver damage.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203840883065-90-5C13H9N5O5S210 mg/50 mg
  • BIO-acetoxime
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361122667463-85-6C18H12BrN3O31 mg/10 mg
  • Bisindolylmaleimide V
    Negative control for the protein kinase C (PKC)-inhibitory activity.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202080113963-68-1C21H15N3O21 mg/5 mg
  • BML-257
    BML-257 is an potent inhibitor of AKT1 translocation and has been observed to attenuate cannabinoid agonist-simulated neurosphere proliferation.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20066632387-96-5C21H14N2O210 mg/50 mg
  • BML-275
    A cell-permeable pyrazolopyrimidine derivative that inhibits AMP Kinase in an ATP-competitive manner. Also inhibits morphogenetic protein signals.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-200689866405-64-3C24H25N5O5 mg/25 mg
  • βARK1 Inhibitor
    A selective inhibitor of βARK1 (β-Adrenergic Receptor Kinase 1). Has no inhibitory activity against protein kinase A (PKA).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221268N/AC12H9NO65 mg
  • BRD 7389
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361129376382-11-5C24H18N2O210 mg/50 mg
  • BTO-1
    A cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20420640647-02-7C9H4N4O4S2 mg
  • CaMKP Inhibitor
    Amino-naphthol sulfonic acid that acts as a competitive substrate inhibitor of Ca2+/CaMKP and the nuclear isoform CaMKP-N. Exhibits little activity against PP2B/CaN and PP2C
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20386652789-62-5C10H8NNAO7S2 ·2H2O100 mg
  • Casein Kinase II Inhibitor III, TBCA
    A cell-permeable tetrabrominated cinnamic acid compound that acts as an ATP-competitive and potent inhibitor of Casein Kinase II with greater selectivity than DMAT and TBB (sc-202830).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203869934358-00-6C9H4Br4O25 mg
  • CAY10622
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3588821038549-25-5C25H25N5O31 mg/5 mg
  • CAY10576
    The NF-κB/Rel transcription factors, known to be involved in the pathogenesis of a variety of diseases and the regulation of pro-inflammatory cytokines, are present in the cytosol in an inactive state, complexed with inhibitory IκB proteins. NF-κB is activated upon degradation of IκB following IKK-α and IKK-β phosphorylation. IKK-ε, a homolog of IKKα and IKK-β, can also activate NF-κB. IKK-ε is expressed primarily in immune cells, and is thought to play a role in the immune response. CAY10576 is a benzimidazole analog that selectively inhibits IKK-ε with an IC50 value of 40 nM and is essentially inactive at IKK-α and IKK-β.1
    Catalog #CAS NumberMolecular FormulaUnit
    sc-223870862812-98-4C22H19N3O5S21 mg/5 mg
  • CCT 137690
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3627221095382-05-0C26H31BrN8O10 mg/50 mg
  • Cell Sheet Migration Inhibitor, Locostatin
    A cell-permeable and potent inhibitor of Raf kinase inhibitor protein (RKIP)/Raf1 kinase interaction.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203875133812-16-5C14H15NO310 mg
  • Cell Sheet Migration Inhibitor, Negative Control
    A cell-permeable N-(butyryl)oxazolidinone compound which serves as a negative control for the Cell Sheet Migration Inhibitor. Displays little bioactivity during wound closure and cell proliferation studies.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221412N/AC14H17NO35 mg
  • Ceramide Kinase Inhibitor, K1
    A cell-permeable tetracyclic quinone compound that acts as a specific, reversible, and non-competitive inhibitor of CerK (ceramide kinase) activity with little effect against SPHK1/2 or DGK. Shown to reduce cellular C1P (ceramide-1-phosphate) synthesis by 40% at 20 µM in a rat basophilic leukemia cell line RBL-2H3 and block CerK-mediated degranulation in both RBL-2H3 and murine BMMC (bone marrow-derived mast cells) in a dose-dependent manner. Exhibits no cytotoxic effect against RBL-2H3 even at concentrations as high as 100 µM.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2214141258005-85-4C21H28O41 mg
  • CID 755673
    A selective and potent protein kinase D1-D3, PKC, CAK, PLK1 and CAMKIIα inhibitor. Reported to inhibit PKD-mediated protein transport and to reverse phorsphorylation of Ser-82 on small heat shock protein 27 (HSP27) in a human neuroblastoma cell line.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205246521937-07-5C12H11NO310 mg
  • Compound 401
    Cell-permeable pyrimido-isoquinolinone compound. Potent, reversible, and ATP-competitive inhibitor of DNA-PK with ~19-fold selectivity over mTOR.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202552168425-64-7C16H15N3O25 mg
  • Compound 56
    The most potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203430171745-13-4C18H18BrN3O2500 µg
  • Cucurbitacin I, Cucumis sativus L.
    Shown to be a Stat3 and JAK2 inhibitor. Also reported to contain in vitro anti-proliferative activity against certain cancer cells .
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2030102222-07-3C30H42O71 mg
  • Cyclapolin 9
    Selective, ATP-competitive polo-like kinase 1 (PLK1) inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20527940533-25-3C9H4F3N3O4S10 mg/50 mg
  • DAG Kinase Inhibitor
    DAG Kinase Inhibitor is an inhibitor of DGK (Diacylglycerol kinase; DAG Kinase) and is useful for elucidating the roles of protein kinase C (PKC). This particular isoform, R59949, has been reported to potentially exhibit selective inhibition of DGK-α.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3551120166-69-0C28H25F2N3OS5 mg
  • Debromohymenialdisine
    Inhibitor of G2 DNA damage checkpoint (IC50=8µM),Chk1 (IC50=3µM) and Chk2 (IC50=3.5µM). DBH does not inhibit ATM or ATM-Rad3-related protein.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20212775593-17-8C11H11N5O2100 µg
  • Dioctanoylglycol
    Diacylglycerol kinase inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203567627-86-1C18H34O450 mg
  • DMH-1
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3611711206711-16-1C24H20N4O10 mg/50 mg
  • DMNB
    Cell-permeable vanillin derivative that acts as a potent and selective inhibitor of DNA-PK activity and DNA-PK-mediated DSB DNA repair by non-homologous DNA-end-joining (NHEJ).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20214220357-25-9C9H9NO510 mg
  • DNA-PK Inhibitor II
    Shown to be a cell permeable potent antiproliferative agent. Reported to reduce lethal damage recovery in cells and DNA double strand break repair.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202143154447-35-5C17H15NO310 mg/50 mg
  • DNA-PK Inhibitor III
    Cell-permeable, potent, selective, and an ATP-competitive inhibitor of DNA-PK and PI 3-Kinase catalytic subunit p110∫.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203928404009-40-1C12H15NO31 mg
  • DNA-PK Inhibitor IV
    A morpholino-salicylaldehyde compound which acts as a potent, selective and ATP-competitive inhibitor of DNA-PK. Inhibits PI 3-K catalytic subunit p110-isozymes at higher concentrations and weakly inhibits a panel of several other kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221562N/AC11H13NO31 mg
  • DNA-PK Inhibitor V
    Potent, selective and ATP-competitive inhibitor of DNA-PK (IC50 = 270 nM); inhibits PI 3-K catalytic subunit p110-isozymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203929404009-46-7C17H17NO31 mg/5 mg
  • Dorsomorphin dihydrochloride
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361173866405-64-3C24H25N5O.2HCl10 mg/50 mg
  • DRB
    Shown to be an adenosine analogue which causes a premature termination of DNA transcription. Also reported to be a mixed-type inhibitor of casein kinase II.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20058153-85-0C12H12Cl2N2O410 mg/50 mg
  • eEF-2 Kinase Inhibitor, NH125
    Inhibits the activity of bacterial histidine kinases (EnvZ, PhoQ, BvgS, and EvgS) and eukaryotic eEF-2 kinase/CaMKIII.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203037278603-08-0C27H45IN25 mg
  • ER 27319 maleate
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361177201010-95-9C18H20N2O.C4H4O410 mg/50 mg
  • FAK Inhibitor 14
    Selective FAK inhibitor that exhibits antiproliferative activity in a variety of human tumor cell lines in vivo, and promotes cell detachment/inhibits cell adhesion in vitro
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2039504506-66-5C6H2(NH2)4 ·4HCl10 mg/50 mg
  • FCCP
    Oxidative phosphorylation uncoupler in mitochondria.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203578370-86-5C10H5F3N4O10 mg/50 mg
  • FGF Receptor Tyrosine Kinase Inhibitor IV, NP603
    A cell-permeable SU6668 derivative that targets the ATP-binding pocket and inhibits the kinase activity of PDGFRβ, FGFR1 and VEGFR2, while showing little activity against EGFR. Exhibits anti-angiogenesis activity and suppress FGF-2-induced proliferation in HUVEC cultures in a dose-dependent manner.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221613N/AC26H26N2O55 mg
  • Flt-3 Inhibitor
    Cell-permeable thienylcarboxamide that acts as a potent, ATP-competitive, and highly selective Flt-3 inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203048301305-73-7C18H20N2O4S5 mg
  • Flt-3 Inhibitor II
    A cell-permeable symmetrical indolylmethanone kinase inhibitor that is more selective to Flt3 over PDGFR; potently induces apoptosis in Flt3-expressing primary AML patient blasts.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203956896138-40-2C17H12N2O31 mg
  • Flt3 Inhibitor IV
    A 3-aminoindazole compound that acts as a strong and ATP-competitive inhibitor of Flt3. It also exhibits excellent selectivity over KDR/VEGFR-2 and c-Kit.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221615N/AC13H12N45 mg/25 mg
  • FPA 124
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361179902779-59-3C11H9Cl2CuN3O2S10 mg/50 mg
  • Genistin
    Isoflavone glycoside found in soy-based foods. An inactive analog of the PTK inhibitor Genistein. Can be used as a negative control for Genistein. Reportedly reduces bone loss in ovarectomized rats.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202168529-59-9C21H20O105 mg
  • Gold sodium thiomalate
    A gold(I) compound that inhibits the activity of IKK (ID50 = 10.9 µM) and disrupts PB1 (Phox and Bem1p) domain-mediated interactions between Par6 and PKCi (IC50 ~ 1 µM) by modifying cysteine residues within the catalytic domain of IKK and the PB1 domain of PKCi. Inhibits PKCi-dependent Rac1 activation in A549 cells.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20383012244-57-4C4H4AuNaO4S50 mg
  • GSK 1059615
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361198958852-01-2C18H11N3O2S10 mg/50 mg
  • GSK 269962
    Catalog #CAS NumberMolecular FormulaUnit
    sc-363279850664-21-0C29H30N8O510 mg/50 mg
  • GSK 429286
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361200864082-47-3C21H16F4N4O21 mg/10 mg
  • GSK 650394
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361201890842-28-1C25H22N2O210 mg/50 mg
  • GSK 690693
    Catalog #CAS NumberMolecular FormulaUnit
    sc-363280937174-76-0C21H27N7O310 mg/50 mg
  • GTP 14564
    A cell-permeable tricyclic benzofurano-indazolo compound which functions as a specific inhibitor of class III receptor tyrosine kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20306234823-86-4C15H10N2O5 mg
  • GW441756 hydrochloride
    A highly selective, potent TrkA kinase inhibitor which is orally active. IC50 = 2 nM.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-215121504433-24-3 (non-salt)C17H13N3O•HCl5 mg
  • GW4869
    A cell permeable, selective inhibitor of N-SMase (neutral sphingomyelinase). This compound functions as an inhibitor, via a non-competitve manner.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2185786823-69-4C30H28N6O2•2HCl5 mg/25 mg
  • H-1152 . dihydrochloride
    Cell permeable, highly specific, and potent ATP-competitive inhibitor of rho-kinase (ROCK) inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203592451462-58-1C16H21N3O2S.2HCl1 mg/5 mg
  • H-1152 Dihydrochloride
    A ROCK Inhibitor. A cell-permeable isoquinolinesulfonamide compoud that acts as a highly specific, potent, and ATP-competitive inhibitor of G-protein Rho-associated kinase (ROCK).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-207727871543-07-6C16H23Cl2N3O2S2.5 mg
  • I-OMe-Tyrphostin AG 538
    This product is an inhibitor of insulin growth factor 1 receptor protein tyrosine kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-300821N/AC17H12INO55 mg
  • IKK-2 Inhibitor XI
    Catalog #CAS NumberMolecular FormulaUnit
    sc-359906N/AC12H11N3O2S5 mg
  • IKK 16
    Selective IκB kinase (IKK) inhibitor (IC50 values are 40, 70 and 200 nM for IKK-2, IKK complex and IKK-1 respectively). Inhibits TNF-α-stimulated IκB degradation and expression of adhesion molecules E-selectin, ICAM and VCAM (IC50 values are 1.0, 0.5, 0.3 and 0.3 μM respectively). In vivo, inhibits LPS-induced TNF-α release and neutrophil extravasion in thioglycollate-induced peritonitis.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204009N/AC28H29N5OS ·HCl10 mg/50 mg
  • IKK-2 Inhibitor VI
    An ureido-thiophenecarboxamide compound acting as a potent inhibitor of IKK-2.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221743N/AC12H11N3O2S1 mg
  • IKK-3 Inhibitor IX
    A thiophenecarbonitrile compound that acts as a potent ATP-competitive inhibitor of IKK-3. Have shown to be inactive against cytochrome P450 isozymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221746N/AC22H19N3O5S25 mg
  • Indirubin-3'-(2,3-dihydroxypropyl)oximether
    c-Src inhibitor blocking downstream STAT3 signalling. Also, induces apoptosis in human cancer cells.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221752N/AC19H17N3O41 mg
  • Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor
    Benzimidazole compound that acts as a cell-permeable, potent selective inhibitor of IL-1 kinases. Shown to exhibit little activity against a panel of 27 other kinases, including, but not limited to, Ick and src.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204013509093-47-4C20H21N5O45 mg
  • IPA 3
    A selective cell permeable Pak1 (group I p21-activated kinase) inhibitor which functions by inhibiting activators from binding to the active sites on the enzyme.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20401642521-82-4C20H14O2S25 mg/50 mg
  • JNK Inhibitor II, Negative Control
    A useful negative control for JNK Inhibitor II. Inhibits JNK2 and JNK3 only at much higher concentrations.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221781N/AC15H10N2O1 mg
  • JNK Inhibitor IX
    A thienylnaphthamide compound that acts as a selective and potent inhibitor of the ATP binding sites of JNK2 and JNK3.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202671312917-14-9C20H16N2OS5 mg
  • JNK Inhibitor V
    Shown to be a nonpeptide ATP competitive inhibitor of JNK signal transduction pathway. Also reported to demonstrate anti-apoptotic capabilities.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202672345987-15-7C20H16N6S5 mg
  • JNK Inhibitor VIII
    A JNK inhibitor that has been reported to suppress apoptosis, caspase cleavage, and cytochrome C release. Studies indicate that the inhibitor can block the phosphorylation of c-Jun and JNKAR1.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202673894804-07-0C18H20N4O45 mg
  • kb NB 142-70
    kb NB 142-70 is a selective protein kinase D (PKD) inhibitor. Demonstrates a 7-fold increase in inhibition potency as an analog of CID 755673 (sc-205246).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-358834N/AC11H9NO2S210 mg/50 mg
  • KH CB19
    Catalog #CAS NumberMolecular FormulaUnit
    sc-362756N/AC15H13Cl2N3O21 mg
  • KI 8751
    Cell-permeable quinolyloxyphenyl-urea compound that acts as a VEGFR-2-selective inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203090228559-41-9C24H18F3N3O45 mg
  • KU 60019
    Catalog #CAS NumberMolecular FormulaUnit
    sc-363284925701-46-8C30H33N3O5S10 mg/50 mg
  • L-779,450
    Potent, ATP-competitive Raf kinase inhibitor (IC50 = 10 nM) that displays > 7, > 30 and > 70-fold selectivity over p38α, GSK3β and Lck respectively. Suppresses DNA synthesis and induces apoptosis in cells that proliferate in response to Raf-1 and A-Raf but not B-Raf.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204046303727-31-3C20H14ClN3O10 mg/50 mg
  • Lavendustin C methyl ester
    Catalog #CAS NumberMolecular FormulaUnit
    sc-221838N/AC15H15NO51 mg/5 mg
  • LFM-A12
    A potent and specific inhibitor of the EGFR tyrosine kinase in vitro (IC50 = 1.7 µM). Has been shown to kill over 99% of human breast cancer cells in vitro by triggering apoptosis. Even at high concentrations (175-350 µM), LFM-A12 does not affect the enzymatic activity of other PTKs including BTK, HCK, IRK, JAK1, JAK3, and Syk.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-295360N/AC12H9F3N2O3500 µg/1 mg
  • LFM-A13
    A potent and selective inhibitor of Bruton's tyrosine kinase (BTK). Inhibits recombinant BTK with an IC50 value of 2.5 μM and has no activity on other protein kinases ( which include JAK1, JAK3, HCK, EGFR kinase and insulin receptor kinase) at concentrations of up to 278 μM.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20362362004-35-7C11H8Br2N2O210 mg/50 mg
  • Linoleoyl Ethanolamide-d4
    Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA). It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Ki values of 10 µM and 25 µM, respectively. However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26. mg/kg). In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.-fold at 15 µM in a CB-receptor-independent manner. However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-29536268171-52-8C20H33D4NO2100 µg/500 µg
  • LY 294002, 4′-NH2
    A cell permeable 4′-amino derivative which inhibits the p110α, p110β, p110δ, and p110γ subunits of Phosphoinositide 3-kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203121942289-87-4C19H18N2O35 mg/50 mg
  • LY 364947
    A diheteroaryl-substituted pyrazole compound used as a selective, ATP-competitive inhibitor of TGF-β Receptor I kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203122396129-53-6C17H12N45 mg/10 mg
  • LY-294,002 hydrochloride
    Catalog #CAS NumberMolecular FormulaUnit
    sc-215273934389-88-5C19H18ClNO31 mg/5 mg
  • Met Kinase Inhibitor
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204801658084-23-2C28H30ClN5O4S1 mg
  • ML-7
    Shown to be an inhibitor of Ca2+ dependent and independent smooth muscle myosin light chain kinases. Also, affects the osmotic volume regulation of cells via stimulation of K-CL cotransport.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-200557110448-33-4C15H17IN2O2S··HCl10 mg/50 mg
  • MNS
    A cell-permeable, cytotoxic β-nitrostyrene derivative which functions as a tyrosine kinase inhibitor that supresses human platelet aggregation.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2022291485-00-3C9H7NO450 mg
  • Myricetin
    A non-ATP competitive MEK1 inhibitor and ATP-competitive inhibitor of CKI, CKII, IR, MLCK, PKA and PKC.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203147529-44-2C15H10O825 mg/100 mg
  • N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide
    Found to have a potent inhibitory action against casein kinase 1 completely with respect to ATP and a much weaker effect on casein kinase 2 and other protein kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-207901120615-25-0C11H12ClN3O2S10 mg
  • N-(4-Pyridyl)-N'-(2,4,6-trichlorophenyl)urea
    Potent, selective, and ATP-competitive inhibitor of Rho kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-22197097627-27-5C12H8Cl3N3O5 mg
  • N-[2-(p-Cinnamylamino)ethyl]-5-isoquinolone Sulfonamide
    Selective inhibitor of Protein Kinase A (cyclic AMP-dependeant Protein Kinase).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-207932130964-40-8C20H21N3O2S10 mg
  • N-alpha-Benzoyl-L-argininamide hydrochloride
    Shown to be a competitive inhibitor of urokinase and used as a substrate for cathepsin,
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3012784299-03-0C13H19N5O2··HCl5 g/25 g
  • N-Boc-erythro-sphingosine
    The N-Boc protected Sphingosine, a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. It does not inhibit protein kinase A or myosin light chain kinase. It inhibits calmodulin-dependent enzymes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-207996609812-03-5C23H45NO425 mg
  • NFκB Activation Inhibitor VI, BOT-64
    A cell-permeable benzoxathiole compound that acts as an IKK-2 inhibitor, by targeting the Ser177 and/or Ser181 residues in the kinase's activation loop domain.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-222062N/AC15H15NO2S5 mg
  • NSC 33994
    Catalog #CAS NumberMolecular FormulaUnit
    sc-36277482058-16-0C28H42N2O210 mg/50 mg
  • OM137
    An inhibitor of aurora kinases. An aminothiazole derivative, which functions to override the spindle checkpoint primarily through inhibition of the Aurora kinases (mitotic kinases). A more potent inhibitor of Aurora B compared with Aurora A in vitro. The compound has some CDK1 inhibitory activity, but is likely that the major mode by which it drives mitotic exit of cells arrested in M phase via the spindle checkpoint is through its inhibitory activity against Aurora B kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-255403292170-13-9C13H14N4O3S5 mg
  • Palmitoyl-L-carnitine Chloride
    Protein kinase inhibitor
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20578918877-64-0C23H45NO4 ·HCl5 mg/10 mg
  • Pamidronate disodium salt hydrate
    A bisphosphonate compound, which inhibits farnesyl diphosphate synthase and bone resorption. This compound stimulates polymorphonuclear leukocyte and platelet derived nitric oxide production.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-27200657248-88-1 (anhydrous)C3H9NO7P2Na2 ·H2O10 mg
  • PD 0325901
    A potent MEK inhibitor that suppresses phosphorylation of ERK1/2 in murine colon 26 tumors with an IC50 value of 0.33 nM.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205427391210-10-9C16H14F3IN2O4500 µg/1 mg
  • PD 161570
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361284192705-80-9C26H35Cl2N7O10 mg/50 mg
  • PD 407824
    Selective inhibitor of checkpoint kinases Chk1 and Wee1 (IC50 values are 47 and 97 nM respectively). Displays selectivity over a range of other protein kinases; IC50 values are 3.4, 3.75, > 5, > 50, > 50 and > 50 μM for PKC, CDK4, other CDKs, c-Src, PDGFR and FGFR respectively.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203660622864-54-4C20H12N2O31 mg/10 mg
  • PF 04217903 mesylate
    Catalog #CAS NumberMolecular FormulaUnit
    sc-363286956906-93-7C19H16N8O.CH3SO3H10 mg/50 mg
  • PF 431396
    Catalog #CAS NumberMolecular FormulaUnit
    sc-362780717906-29-1C22H21F3N6O3S10 mg
  • PF 4708671
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361288N/AC19H21F3N610 mg/50 mg
  • PF 477736
    Catalog #CAS NumberMolecular FormulaUnit
    sc-362781952021-60-2C22H25N7O210 mg/50 mg
  • PF 4800567 hydrochloride
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3627821188296-52-7C17H18ClN5O2.HCl10 mg/50 mg
  • PF 573228
    A selective and potent focal adhesion kinase inhibitor that reportedly displays 50-250-fold selectivity for FAK over other protein kinases
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204179869288-64-2C22H20F3N5O3S10 mg/50 mg
  • PF 670462
    A selective casein kinase, CK1ε and CK1δ inhibitor which also shows potency against 42 other kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204180950912-80-8C19H20FN5•2HCl10 mg/50 mg
  • PHA 665752
    A small molecule, ATP competitive inhibitor of the catalytic activity of c-Met tyrosine kinase with apoptotic properties.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203186477575-56-7C32H34Cl2N4O4S2 mg
  • PI-103
    A cell-permeable pyridinylfuranopyrimidine compound that acts as an ATP-competitive dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR complex 1 and 2.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203193371935-74-9C19H16N4O31 mg/5 mg
  • PIM-1 Inhibitor 2
    Potent Pim-1 kinase inhibitor (Ki = 91 nM).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204194477845-12-8C17H11CIN4O10 mg/50 mg
  • PKC-412
    Reported to be an antiproliferatiive agent which inhibits protein kinase C. Additionally shown to increase endothelial nitric oxide (NO) synthase expression and NO production.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-200691120685-11-2C35H30N4O41 mg/5 mg
  • PknG Inhibitor
    A cell-permeable tetrahydrobenzothiophene compound that acts as a highly specific and ATP-binding site-targeting inhibitor against mycobacterial protein kinase G (PknG; IC50 = 390 nM), while exhibiting much reduced or no activity against 8 other mycobacterial and 25 other human kinases, including PKCα, the mammalian kinase most closely related to PknG. AX20017 is shown to completely inactivate PknG-mediated blockage of lysosomal transfer and degradation of M. bovis BCG in macrophages at concentrations (10µM or higher) that does not otherwise affect the growth of BCG outside its infected host.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-222180329221-38-7C13H16N2O2S10 mg
  • PKR Inhibitor
    The RNA-dependent protein kinase (PKR) inhibitor can inhibit RNA-induced PKR autophosphorylation and rescue PKR-dependent translation block.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204200608512-97-6C13H8N4OS5 mg
  • PKR Inhibitor, Negative Control
    An oxindole compound that serves as a negative control for PKR Inhibitor. Shown to be inactive in inhibiting RNA-induced PKR autophosphorylation (IC50> 100 µM) or in rescuing PKR-dependent translation block.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204201852547-30-9C15H8Cl3NO210 mg
  • Polo-like Kinase Inhibitor III
    Cell-permeable thiophene-benzimidazole compound that acts as a potent and reversible inhibitor against polo-like kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203202660868-91-7C22H18F3N3O4S500 µg
  • PP 3
    Negative control for the Src family protein tyrosine kinase inhibitor PP2. However, it inhibits the activity of EGFR kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2032135334-30-5C11H9N51 mg
  • PP1 Analog II, 1NM-PP1
    Cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203214221244-14-0C20H21N51 mg/5 mg
  • Protein Kinase Inhibitor, DMAP
    Puromycin analog inhibits protein kinases. Inhibits TNF-α upregulation of ICAM-1, lipolysis, and the activation of JNK/SAPK.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203220938-55-6C7H9N550 mg
  • Pseudohypericin
    A specific inhibitor of protein kinase C and D-β-H, an apoptosis inducer, and selective antagonist of corticotropin-releasing factor in murine models.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20277755954-61-5C30H16O91 mg/5 mg
  • psi-Tectorigenin
    Shown to inhibit EGF-receptor Tyrosine Kinase leading to a block of phosphatidylinositol turnover.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-29686513111-57-4C16H12O6250 µg
  • Quercetagetin
    A cell-permeable flavanol compound that acts a potent, ATP-competitive, and reversible inhibitor of PIM1 kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20422190-18-6C15H10O85 mg
  • Quercetin Dihydrate
    A ubiquitous natural flavonoid with antiproliferative properties. Inhibits PI 3-kinase, PI 4-kinase and PI-4-phosphate 5-kinase, and reduces IP3 levels, blocking oncogenic signaling. Induces apoptosis of cells in G1 and S.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2032256151-25-3C15H10O7 ·2H2O5 g/25 g
  • rac-3-Octadecanamido-2-Methoxypropan-1-ol Phosphocholine
    Shows strong inhibitory action against neoplastic cell growth in vitro. Inhibits Protein Kinase C.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-208288163702-19-0C27H57O6N2P•1.5H2O10 mg
  • Raf Kinase Inhibitor IV
    Cell-permeable triarylimidazole compound that acts as a reversible, ATP-competitive, and highly potent inhibitor of Raf kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203233303727-31-3C20H14ClN3O•xH2O1 mg
  • Raf Kinase Inhibitor V
    A cell-permeable azaindole compound that acts as a potent, ATP-site targeting and reversible inhibitor of Raf kinase with excellent selectivity over 64-other kinases. Shown to block ERK phosphorylation, induce cell cycle arrest and apoptosis in several B-RafV600E melanoma cells.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-222241N/AC17H14ClF2N3O3S1 mg
  • Rho Kinase Inhibitor III, Rockout
    A cell permeable ATP-competitive Rho Kinase inhibitor observed to inhibit the blebbing and promote cell spreading.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2032377272-84-6C13H10N25 mg
  • Rho Kinase Inhibitor IV
    A glycyl analog of Rho-Kinase Inhibitor which inhibits ROCK with an improved selectivity at 6 nM.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-222254913844-45-8C18H24N4O3S•2HCl1 mg
  • Rho Kinase Inhibitor V
    A cell-permeable pyrazolyl carboxamide compound that acts as a potent, ATP-binding pocket-targeting inhibitor of ROCK-II and effectively inhibits the myosin light chain 2 phosphorylation on Thr18/Ser19 in A7r5 cells. It affects the activities of PKA, MRCK, Akt1 and CYP-450 enzymes only at much higher concentrations.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2222551072906-02-5C18H15N3O35 mg
  • Ro-31-8220 in solution
    Catalog #CAS NumberMolecular FormulaUnit
    sc-358721138489-18-6C25H23N5O2S ·CH3SO3H1 mg
  • Rottlerin
    Inhibitor of CaM kinase III, PKC δ, PKC α, PKC β, PKC ε, PKC η and PKC ζ, but with significantly reduced potency; also a hERG activator.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-355082-08-6C30H28O810 mg
  • Rp-8-CPT-cAMPS
    Lipophilic analog of the competitive inhibitor of protein kinase A (cyclic AMP antagonist).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-215821129735-01-9C16H14ClN5O5PS2 ·Na5 µmol
  • RPI-1
    A competitive, potent ATP-dependent Ret kinase inhibitor. The compound also inhibits c-Met. Increased tumorigenicity, motility, and invasiveness have been described as biological consequences of HGF/Met deregulation in tumor cells, thus not surprisingly RPI-1 treatment of H460 cells resulted in a strong reduction of both colony number and size. The compound is also active at mouse NSCLC H460 xenograft tumor and metastasis model. Mechanistically RPI-1 inhibits Met phosphorylation at Tyr1234/Tyr1235, known to activate the intrinsic kinase activity.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-255524269730-03-2C17H15NO45 mg
  • SB 590885
    Catalog #CAS NumberMolecular FormulaUnit
    sc-363287405554-55-4C27H27N5O210 mg/50 mg
  • SBE 13 hydrochloride
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3627951052532-15-6C24H27ClN2O4.HCl10 mg/50 mg
  • SC-514
    A selective and reversible inhibitor of IκB kinase 2 (IKK2); displays greater than 10-fold selectivity over 28 other kinases, including JNK, p38, MK2, and ERK.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205504354812-17-2C9H8N2OS25 mg/10 mg
  • Scytonemin
    An indolic-phenolic pigment and a photo-stable UV shield in prokaryotes. Also found to be an inhibitor of polo-like kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202337152075-98-4C36H20N2O41 mg
  • SD 1008
    JAK2/STAT3 signaling pathway inhibitor which additionally inhibits Src.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-358791960201-81-4C18H19NO510 mg/50 mg
  • SH-5
    Inhibitor of Akt (PKB) activation without affecting activation of the upstream kinase PDK-1, or other kinases downstream of Ras such as MAPK. Induces apoptosis and kills a variety of cancer cell lines containing high levels of active Akt and depending upon Akt for survival.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205973N/AC29H59O10P0.5 mg/1 mg
  • SH-6
    Inhibitor of Akt (PKB) activation without affecting activation of the upstream kinase PDK-1, or other kinases downstream of Ras (such as MAPK). Induces apoptosis and kills a variety of cancer cell lines containing high levels of active Akt and depending upon Akt for survival.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205974N/AC28H57O9P0.5 mg/1 mg
  • SKI II
    Selective non-lipid inhibitor of sphingosine kinase (IC50 = 0.5 μM); does not act at ATP-binding site. Displays no inhibition of ERK2, PI 3-kinase, or PKCα at concentrations up to 60 μM. Reduces levels of sphingosine-1-phosphate in MDA-MB-231 breast cancer cells. Induces apoptosis and inhibits proliferation in several other tumor cell lines in vitro (IC50 = 0.9-4.6 μM).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204286312636-16-1C15H11ClN2OS10 mg/50 mg
  • SL 0101-1
    A selective kinase inhibitor shown to inhibit p90 ribosomal S6 kinase, without inhibiting upstream kinases such as Raf, MEK and PKC.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20428777307-50-7C25H24O121 mg
  • Smad3 Inhibitor, SIS3
    A cell-permeable pyrrolopyridine compound that selectively inhibits TGF-β1-dependent Smad3 phosphorylation and Smad3-mediated cellular signaling with no effect on Smad2, p38 MAPK, ERK, or PI 3-K signaling.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2223181009104-85-1C28H27N3O31 mg
  • SP600125
    Potent, selective and reversible inhibitor of JNK1,-2, and -3. An ATP competitive inhibitor with >20 fold selectivity versus a range of similar kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-200635129-56-6C14H8N2O10 mg/50 mg
  • SR 3677 hydrochloride
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3613641072959-67-1C22H24N4O4.HCl10 mg/50 mg
  • ST638
    Protein tyrosine kinase inhibitor that also inhibits HGF-induced MAP kinase activation in hepatocytes. Inhibits phospholipase D activity in human neutrophils.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202344107761-24-0C19H18N2O3S5 mg
  • Staurosporine
    Catalog #CAS NumberMolecular FormulaUnit
    sc-36025862996-74-1C28H26N4O3100 µl
  • STO-609
    A selective ATP-competitive Ca2+/calmodulin-dependent protein kinase inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20282052029-86-4C19H10N2O3 ·CH3CO2H5 mg
  • SU 3327
    A selective inhibitor of c-Jun N-terminal kinase (JNK) (IC50 = 0.7 μM). Shown to inhibit the protein-protein interaction between JNK and JIP (IC50 = 239 nM). Displays selectivity over p38 MAPK and Akt and restores insulin sensitivity in a mouse model of type-2 diabetes.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-29643040045-50-9C5H3N5O2S310 mg/50 mg
  • SU 4312
    SU 4312 is a selective and potent vascular endothelial cell growth factor receptor (VEGFR) inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-2006375812-07-7C17H16N2O5 mg/25 mg
  • SU 4984
    Inhibitor of tyrosine kinase activity of fibroblast growth factor receptor 1 (FGFR1). Inhibits αFGF-induced tyrosine phosphorylation of ERK1 and ERK2 and the tyrosine phosphorylation of the PDGF receptor and the insulin receptor. Does not inhibit the kinase activity of the EGF receptor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205977186610-89-9C20H19N3O21 mg
  • SU 5402
    A FGFR-specific tyrosine kinase inhibitor. Research shows that inhibition of FGFR results in the blocking of NVPs secretion and an increase of Ca2+.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204308215543-92-3C17H16N2O31 mg/5 mg
  • SU1498
    Demonstrates reversible, potent ATP-competitive and selective inhibitor of Flk-1 kinase, a vascular endothelial growth factor (VEGF) receptor kinase. Able to reduce expression of ets-1, a transcription factor stimulated by VEGF. Can potentially act as an angiogenesis inhibitor, as well.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-355982N/AC25H30N2O25 mg
  • SU6656
    A potent, selective Src family kinase inhibitor known to inhibit c-Src, Fyn, c-Yes, Lyn, Lck and PDGF receptor kinase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203286330161-87-0C19H21N3O3S1 mg
  • SX 011
    A selective p38α, p38β and JNK-2 inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-358841309913-42-6C26H27ClFN3O310 mg
  • Syk Inhibitor IV, BAY 61-3606
    Cell-permeable imidazopyrimidine. Potent, ATP-competitive, reversible, and highly selective inhibitor of Syk and Syk-mediated cellular functions.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202351732983-37-8C20H21ClN6O42 mg
  • TAK 715
    Catalog #CAS NumberMolecular FormulaUnit
    sc-362799303162-79-0C24H21N3OS10 mg/50 mg
  • (+/-)-Taxifolin hydrate
    An antioxidant flavenoid.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-25819224198-97-8C15H12O7 ·xH2O25 mg
  • TC-A 2317 hydrochloride
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3632911245907-03-2C19H28N6O.HCl10 mg/50 mg
  • TCS 2002
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3590201005201-24-0C18H14N2O3S10 mg/50 mg
  • TCS 21311
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3628041260181-14-3C27H25F3N4O410 mg/50 mg
  • TCS 2312 dihydrochloride
    Potent and selective checkpoint kinase 1 (chk1) inhibitor (Ki = 0.38 nM, EC50 = 60 nM). Enhances the cell killing activity of Gemcitabine in breast and prostate cancer cell lines. Displays antiproliferative effects in vitro.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204326838823-32-8C25H24N4O2.2HCl1 mg
  • TCS PIM-1 1
    ATP-competitive Pim-1 kinase inhibitor that displays selectivity over Pim-2 and MEK1/2 (IC50 values are 50, > 20000 and > 20000 nM for Pim-1, Pim-2 and MEK1/2 respectively).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204330N/AC18H11BrN2O210 mg/50 mg
  • TCS PIM-1 4a
    A selective, ATP-competitive Pim kinase inhibitor (IC50 values are 24 and 100 nM for Pim-1 and Pim-2 respectively). Shown to display selectivity over a panel of ~50 other kinases tested. Also exhibits cytotoxicity in PC3 prostate carcinoma cells in vitro (IC50 = 17 μM).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-296450438190-29-5C11H6F3NO2S10 mg/50 mg
  • Terreic Acid
    Terreic acid is a metabolite that displays antibiotic properties. It has been found to inhibit the catalytic activity of BTK.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-200655121-40-4C7H6O41 mg/5 mg
  • TG 003
    Catalog #CAS NumberMolecular FormulaUnit
    sc-362808719277-26-6C13H15NO2S10 mg/50 mg
  • TGF-β RI Kinase Inhibitor III
    A cell-permeable imidazolyl-pyridine compound that acts as a potent, ATP-competitive, reversible, and selective inhibitor of activin receptor-like kinase 4 (IC50 = 129 nM), 5 ( IC50 = 47 nM), and 7. It inhibits p38 MAPKα only at much higher concentrations (IC50 = 10.6 µM) and has little effect against ALK1/2/3/6 as well as a panel of 26 other kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204341356559-13-2C20H21N3O2 ·HCl2 mg
  • TGF-β RI Kinase Inhibitor V
    A selective and reversible inhibitor, which suppresses TGF-β RI/ALK5 signaling.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203294627536-09-8C17H10ClFN62 mg
  • TGF-β RI Kinase Inhibitor VIII
    Cell-permeable quinoxaline compound that is an ATP-competitive inhibitor against type I TGF-βreceptor TbR-I/ALK5.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-203295356559-20-1C21H21N52 mg
  • TMCB
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361383905105-89-7C11H9Br4N3O210 mg/50 mg
  • Torin 2
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3628111223001-51-1C24H15F3N4O10 mg/50 mg
  • Tozasertib
    Catalog #CAS NumberMolecular FormulaUnit
    sc-358750639089-54-6C23H28N8OS25 mg/50 mg
  • Tpl2 Kinase Inhibitor
    Tpl2 Kinase Inhibitor is a reversible naphthyridine ATP-competitive inhibitor of the enzyme Tpl2 kinase. The enzyme is a hematopoietically expressed serine-threonine kinase responsible for regulating tumor necrosis factor-α, toll-like receptor, and G protein–coupled receptor signaling.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204351871307-18-5C21H14ClFN61 mg
  • Triciribine
    Known to suppress the phosphorylation level and kinase activity of Akt. Selectively inhibits Akt1, -2, and -3 without inhibiting known upstream activators, PDK1 and PI 3-Kinase, of Akt.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20066135943-35-2C13H16N6O41 mg/5 mg
  • TX-1123
    May be useful as a therapeutic agent for cancer treatment in animal models. A cell-permeable, reversible and substrate-competitive arylidene-cyclopentenedione derived tyrphostin that acts as a kinase inhibitor for Src, eEF2-K, and PKA (IC50 = 2.2, 3.2, and 9.6 µM, respectively). Has been shown to inhibits EGFR-K and PKC, but only at much higher concentrations (IC50 = 320 µM). Reported to exhibit potent anti-tumor activity (EC50 = 3.66 and 39 µM in HepG2 and HCT116 tumor cells, respectively) with greatly reduced mitochondrial- (≥1000-fold) and hepato-toxicity (≥50-fold) when compared with another tyrphostin, AG 17 (sc-200568 and sc-200568A).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-296675157397-06-3C20H24O310 mg
  • TWS 119 ditrifluoroacetate
    Catalog #CAS NumberMolecular FormulaUnit
    sc-358727601514-19-6 (non-salt)C18H14N4O2•2CF3CO2H10 mg
  • TX-1918
    May be useful as a therapeutic agent for cancer treatment in animal models. A cell-permeable arylidene-cyclopentenedione derived tyrphostin that acts as a potent inhibitor for eEF2-K (IC50 = 440 nM). Has been shown to inhibit other kinases at much higher concentrations (IC50 = 4.4, 44, 44, and 440 µM for Src, PKA, PKC, and EGFR-K, respectively). Reported to exhibit potent anti-tumor activity (EC50 = 2.07 and 230 µM in HepG2 and HCT116 tumor cells, respectively) with greatly reduced mitochondrial- (≥5000-fold) and hepato-toxicity (≥90-fold) when compared with another tyrphostin, AG 17 (sc-200568 and sc-200568).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-296676N/AC14H12O310 mg
  • Tyrene CR4
    Cell-permeable, reversible, and substrate competitive hydroxystryrylacrylonitrile tyrosine kinase inhibitor that show anti-tumor properties. Potently inhibits the kinase activities of JAK2 and Bcr-Abl (IC50 ~100-600 nM and 500-700 nM, respectively). Displays excellent selectivity over other tyrosine kinases, Btk, Lck, Lyn, Src, Syk and ZAP-70 (IC50 >5 µM). Has been shown to preferentially induce apoptosis in acute lymphoblastic (ALL) and myeloid leukemia cells (AML), while exhibiting little deleterious effect towards normal bone marrow cell differentiation and proliferation. Has been reported to be more potent than AG 490 (sc-202046) in inducing ALL cells growth arrest (IC50 ~ 120 nM vs. 5-25 µM). Its in vivo efficacy in cancer reduction has been successfully demonstrated in NOD-SCID mice engrafted with human Ph+ ALL cells.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-296677N/AC19H16N2O35 mg
  • Tyrphostin 9 (RG-50872, Malonaben, SF 6847)
    Reported to be tyrosine kinase protein inhibitor and potent reversible inhibitor of PDGF-induced mitogenesis.Also reported to inhibit actin ring formation and bone resorption in murine osteoclasts.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20056810537-47-0C18H22N2O50 mg/250 mg
  • Tyrphostin AG 1433
    A specific and potent inhibitor of PDGF-β receptor kinase (IC50 = 5.0 µM) and of KDR/Flk-1/VEGF Receptor 2 (IC50 = 9.3 µM). Also acts as angiogenesis inhibitor.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-205984168836-03-1C16H14N2O21 mg/5 mg
  • Tyrphostin B42
    A potent inhibitor of the JAK-2 tyrosine kinase that preferentially inhibits JAK-2 over other kinases.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3556133550-30-8 C17H14N2O35 mg
  • U0124
    Inactive analog of U0126. Used as a negative control. Doesn’t inhibit MEK at concentrations up to 100 μM.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-204934108923-79-1C8H10N4S210 mg
  • UCN-01
    A Staurosporine (sc-3510) analogue that acts as a selective inhibitor of protein kinase C, potently inhibits MK2, induces UCN-01 G1 phase accumulation, dephosphorylates Rb and CDK2 proteins, and induces CDK inhibitor p21/Cip1/WAF1/Sdi1.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202376112953-11-4C28H26N4O4500 µg
  • UCN-02
    Indolocarbazole isolated as a minor co-metabolite of high producing staurosporine strains of selected actinomycetes. Less selective than isomer UCN-01, UCN-02 exhibits comparable activity.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202377121569-61-7C28H26N4O4500 µg
  • VEGF Inducer, GS4012
    This is a cell-permeable pyridinyl-thioether compound which acts as a potent inducer of VEGF and VEGF-mediated vessel formation. GS4012-induced upregulation of VEGF correlates well with its ability to suppress the gridlock/coarctation phenotype (7.5 µg/ml) in Zebrafish as well as to stimulate tubule network formation (5 µg/ml) in HUVECs.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-222411N/AC14H15NOS ·HCl10 mg
  • VX 702
    Catalog #CAS NumberMolecular FormulaUnit
    sc-361400479543-46-9C19H12F4N4O2•xH2O10 mg
  • W-12, Hydrochloride
    Calmodulin antagonist that inhibits myosin light chain kinase and Ca2+-calmodulin-dependent phosphodiesterase.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-20330989108-46-3C14H18N2O2S ·HCl1 mg
  • XMD 8-92
    Catalog #CAS NumberMolecular FormulaUnit
    sc-3614081234480-50-2 (free base)C26H30N6O3 ·C2HF3O210 mg/50 mg
  • Y-27632 dihydrochloride monohydrate
    A potent, cell-permeable, ROCK (Rho-associated coiled coil forming protein serine/threonine kinase) inhibitor, that has also been shown to, ATP-competively, inhibit ROCK-II.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-216067331752-47-7C14H21N3O ·2HCl ·H2O1 mg/5 mg
  • ZM 323881 hydrochloride
    A potent and selective inhibitor of human vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) activity. Inhibits VEGF-A-induced endothelial cell proliferation in vitro (IC50 = 8 nM). Selectively inhibits VEGFR-2 (IC50 = 2 nM) over VEGFR-1 and a range of other receptor tyrosine kinases such as PDGFRβ, FGFR1, EGFR and erbB2 (IC50 > 50 μM).
    Catalog #CAS NumberMolecular FormulaUnit
    sc-296861324077-30-7C22H18FN3O2•HCl1 mg/10 mg
  • ZM 336372
    A reversible tyrosine kinase modulator selectively inhibiting protein kinase c-Raf.
    Catalog #CAS NumberMolecular FormulaUnit
    sc-202857208260-29-1C23H23N3O31 mg
  • ZM-306416
    VEGF receptor tyrosine kinase inhibitor. Inhibits KDR (IC50= 100nM ) and Flt (IC50= 2µM) tyrosine kinases .
    Catalog #CAS NumberMolecular FormulaUnit
    sc-200676690206-97-4C16H13ClFN3O21 mg/10 mg